AbbVie Unusual Options Activity
Portfolio Pulse from Benzinga Insights
A significant investor has taken a bearish stance on AbbVie (NYSE:ABBV), with 54% of the investors opening trades with bearish expectations. The whales have been targeting a price range from $75.0 to $160.0 for AbbVie over the last 3 months. The current price of ABBV is down -0.52% at $147.47. Raymond James has downgraded its action to Outperform with a price target of $177.
October 09, 2023 | 6:16 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Bearish stance by a significant investor could potentially impact AbbVie's stock negatively in the short term. However, Raymond James' Outperform rating with a price target of $177 suggests a positive outlook.
The bearish stance by a significant investor indicates a potential negative impact on AbbVie's stock. However, the Outperform rating by Raymond James suggests a positive outlook, which could balance the negative sentiment.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100